Director of Pro-Dex, Inc. Sells $35,070 Worth of Stock

Director Raymond E. Cabillot of Pro-Dex, Inc. (NASDAQ:PDEX) recently sold 835 shares of the company's stock on January 23rd. The shares were sold at an average price of $42.00 each, resulting in a total transaction value of $35,070.00. After this sale, Cabillot holds 334,646 shares of Pro-Dex, which are valued at approximately $14,055,132. This transaction reflects a 0.25% decrease in Cabillot's ownership stake in the company. Details surrounding the sale can be found in a legal filing with the Securities and Exchange Commission.

Pro-Dex Stock Insights

On Friday, Pro-Dex shares opened at $40.66. The company has seen a 1-year low of $16.18 and a high of $59.60 during this period. Pro-Dex has a market capitalization of $132.55 million, with a price-to-earnings ratio of 26.40 and a beta of 0.56. Financial ratios indicate a debt-to-equity ratio of 0.36, a current ratio of 3.41, and a quick ratio of 1.94. The 50-day and 200-day simple moving averages stand at $47.87 and $33.56, respectively.

Recent Analyst Ratings

In recent weeks, various analysts have provided updated insights on Pro-Dex. Ascendiant Capital Markets raised their target price for the stock from $30.00 to $52.00, assigning it a "buy" rating in a report published on November 11th. Furthermore, StockNews.com upgraded Pro-Dex from a "buy" rating to a "strong-buy" rating on December 14th.

Institutional Investment Trends

A number of institutional investors and hedge funds have adjusted their positions in Pro-Dex recently. Ritholtz Wealth Management acquired a new position in the fourth quarter, valued at about $572,000. Renaissance Technologies LLC increased its holdings by 7.9% in the second quarter, amassing a total of 12,240 shares valued at $240,000 after purchasing an additional 900 shares. Additionally, FMR LLC boosted its stake by 34.9% in the third quarter to own 3,973 shares valued at $119,000. Geode Capital Management LLC also increased its position by 9.1%, owning 27,435 shares valued at $819,000. Overall, institutional ownership stands at 15.28% of Pro-Dex's stock.

About Pro-Dex, Inc.

Pro-Dex, Inc. specializes in the design, development, manufacturing, and sales of powered surgical instruments for medical device original equipment manufacturers on a global scale. Their product offerings include autoclavable, battery-powered, electric, and multi-functional surgical drivers and shavers, primarily targeted toward orthopedic, thoracic, and craniomaxillofacial markets.

Director, Stock, Sale